NOS1 and type 2 diabetes mellitus: Furthermore, our findings that metformin in both short- and long-time experiments almost abolished iNOS activity both in combination with glibenclamide and high glucose lend support to our current hypothesis, that overactivity of the beta-cell NOS-NO system contributes significantly to the development of nonimmunogenic type 2 diabetes.